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ABSTRACT

Inducible cAMP Early Repressor (ICER) is a small transcription factor that
originates from an intronic promoter within the cAMP Response Element Modulator
(CREM) gene (Molina et al., 1993). ICER acts as a putative tumor suppressor by
mediating cAMP antiproliferative activity by competitively binding to cAMP Response
Elements (CRE’s) and repressing transcription of genes involved in cell division (Mémin
et al., 2002). ICER has been shown to be effectively absent in cancer and suspected to be
targeted for proteasomal degradation via ubiquitination (Healey et al., 2013). ICER is
most likely regulated via post-translational modifications as a result of mutations on
Ras/Raf oncogenes (Healey et al., 2013). For example, it has been shown that in cancer,
mutant activated GTP bound Ras protein continuously activates Braf, which in turn,
results in over activation of the Mitogen Activated Protein Kinases, ERK1/ERK2 (Zhang
and Liu, 2002). ICER is thought to be phosphorylated by ERK1/ERK2 and subject to
proteasomal degradation; a result of ubiquitination in Ras/MAPK-mediated melanoma
tumorigenesis (Healey et al., 2013). Melanoma cells rapidly apoptosed when transfected
with a mutant form of ICER that did not contain any lysine residues. This was most likely
because the transcriptional repressor ICER was unable to be ubiquitinated. While this
highlights ICER’s importance in cell division and growth, it is challenging to study the
effects of ICER in melanoma if cells are unable to survive. One method to circumvent
this issue is to create an inducible cell line, in which a mutant form of ICER with no
lysine residues is under a promoter whose expression can be toggled on and off,
dependent on the presence of a transactivator. This requires that mutated ICER be
knocked-in to an alternative location in the human genome, and that wildtype ICER be
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efficiently knocked-out in order to solely study the effects of the mutant. In this
experiment, CRISPR Cas9 mediated genetic editing was used to knockout ICER, while
mitigating off target effects on CREM gene, in an attempt to maintain otherwise normal
cell physiology. The target loci of interest in this experiment was the Kozak consensus on
an ICER specific promoter and the target of the guide RNA (gRNA) for Cas9
endonuclease activity. Amplicon Libraries of DNA extracted from cells transiently
transfected with plasmid containing gRNA and Cas9-GFP cassette and empty vector
expressing only EGFP (control) were generated with Nextera index adaptors. Paired-end
sequencing on the Illumina Miseq provided sufficient coverage depth to determine how
efficient the gRNA was at generating insertions/deletions (indels) or substitutions at the
desired loci. Sequencing data between Experimental and Control was first reviewed using
CRISPResso, an online bioinformatic tool that analyzes deep sequencing data. An
additional bioinformatic analysis was designed and performed to corroborate
CRISPResso results and identify any other low-level variants.
The goal of this experiment was to develop the workflow to identify possible
indels/substitutions that resulted from CRISPR Cas9 induced genetic alteration. This was
done with the expectation of identifying a possible knockout of ICER, while minimally
affecting CREM. Although no variants identified suggest an ICER knockout, a scalable
workflow is now in place to facilitate this stage of the experiment.
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Introduction
Inducible cAMP Early Repressor (ICER) is a small transcription factor that
originates from an intronic promoter within the cAMP Response Element Modulator
(CREM) gene (Molina et al., 1993). ICER acts as a putative tumor suppressor by
mediating cAMP antiproliferative activity (Mémin et al., 2002). It has been demonstrated
that ICER arrests cells at G1/S and G2/S checkpoints of the cell cycle and thus inhibits
cell growth and division (Razavi et al., 1998). Cytosolic factors from the cAMP pathway
phosphorylate cAMP Response Element Binding Protein (CREB) and CREM, activating
transcription of CRE (cAMP Response Element) containing genes. ICER regulates cell
division by competitively binding to CRE’s and preventing CRE-mediated gene
transcription. ICER, as an antagonist to CREB and CREM, prevents expression of
proteins critical for cell division, such as cyclin A, cyclin D and c-fos (Mémin et al.,
2011). ICER, itself, is a product of CRE’s and therefore can regulate its own expression
via cAMP driven gene expression (Yehia et al., 2001). In normal cell physiology, this
autoregulation of a protein involved in mitosis is advantageous and helps maintain cell
division regulation and homeostasis.
While ICER’s importance in regulating cell division is apparent, it has also been
shown that ICER is effectively absent in melanoma cells (Healey et al., 2013). This
makes ICER a protein of interest with regard to cancer research and possible targeted
therapeutic mechanisms. One explanation for ICER’s apparent absence in cancer is that
ICER is targeted for proteasomal degradation (via ubiquitination), a result of Ras/MAPKmediated melanoma tumorigenesis (Healey et al., 2013). In cancer, common mutations
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on the RAS gene for example, results in activated Ras protein that continuously activates
Braf (Zhang and Liu, 2002). Overactive Braf activates the Mitogen Activated Protein
Kinases (MAPK’S) Extracellular Signal-Related Kinases (ERK1/2) at much higher rate
than in non-diseased cells (Zhang and Liu, 2002). One function of the proteins ERK1 and
ERK2 is that they phosphorylate ICER at a critical Serine (Ser 41). In experiments
performed in the lab of Dr. Molina, in which the Ser41 on ICER is mutated, the half-life
of ICER is 4-5 hours longer than the wild types. This suggests that phosphorylation of
this serine is required for ICER to be efficiently ubiquitinated and targeted for
destruction. Further, ICER can also be phosphorylated by CDK1 at Ser 35, which results
in a mono-ubiquitinated ICER, and re-localization of ICER to the cytoplasm (Mémin et
al., 2011). This behavior is increased in cancer cells and suggests a rapid mechanism to
deregulate ICER and promote cell division. Additionally, mono-ubiquitinated ICER
could have an unknown secondary function as a result of this relocation. The idea that
ICER’s tumor suppressor capability is diminished in melanoma via post-translational
modification is supported by static mRNA expression (Healey et al., 2013
It has been shown that ubiquitination occurs primarily on lysine residues of
protein targets (Mattiroli and Sixma 2014). Current unpublished research at the time of
this thesis from Dr. Molina’s laboratory suggests that melanoma cells rapidly apoptosed
when transiently transfected with a plasmid expressing a form of ICER in which all
lysine residues were converted to arginine (NKO-ICER). This further supports the claim
that ubiquitination is responsible for ICER degradation in these diseased cell states.
While the mechanism for destruction of ICER is somewhat understood, what is less clear
is how ICER relates to a tumorigenic phenotype. In order to study the effects of ICER on
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cancer cell growth in more detail it is necessary to control NKO-ICER expression so cells
remain viable and not immediately undergo apoptosis.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and the
CRISPR associated endonuclease 9 (Cas9), functions in nature as an adaptive immune
system for bacteria and archaea (Deveau et al., 2008). Although these repeat sequences
originally caught the attention of researchers in 1987, the function of the spaces between
the repeats as a bacterial adaptive immune system was not recognized until 2007
(Horvath et al., 2010, Barrangou et al., 2007). In 2012, Jennifer Doudna and others
published a landmark paper describing how to utilize CRISPR Cas9, as a programmable
tool to permanently alter the genome (Hsu et al., 2014). Since this time, a flood of
research has been done using the CRISPR Cas9 system to knockout genes in a variety of
organisms, including cancer cells (Jafari et al., 2017).
Genome editing mediated by CRISPR Cas9 relies on two cellular repair
mechanisms; Non-Homologous End Joining (NHEJ) and Homology Directed Repair
(HDR) (Ran et al., 2013). The former is typically favored when generating a knockout
because, as the cell attempts to repair the double-stranded break through NHEJ,
mutations arise that can permanently alter DNA sequence, and thus protein
structure/function (Ran et al., 2013). NHEJ is initiated by a protein named Ku that
recognizes double stranded DNA breaks and attempts to form a bridge between the two
ends to prevent degradation (Pastwa and Błasiak, 2003). Severed double stranded DNA
must be blunted in order to be ligated together. This occurs by DNA synthesis via DNA
polymerase or alternatively DNA overhangs are removed by exo-nuclease (Pastwa and
Błasiak, 2003). The DNA blunting step is particularly prone to generating
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insertions/deletions (indels) or Single Nucleotide Polymorphisms (SNP’s). Once the
severed ends of the DNA are blunted, DNA ligase attaches both ends of DNA (Pastwa
and Błasiak, 2003). This error-prone process has been used in many different applications
to generate efficient knockouts.
To facilitate future experiments using NKO-ICER, we devised a plan to insert
NKO-ICER into the genome under the regulation of an inducible promoter.
Specifically, the central component will be to knock-in NKO-ICER into what is known
as a safe-harbor site. The safe-harbor site, also known as Adeno Associated Viral
Integration Site (AAVS1), is a locus in the human genome that has been shown to be
utilized in transgene integration (Tiyaboonchai et al., 2014). One advantage of a knock-in
via AAVS1 transgene integration is a dramatic reduction in gene silencing or negative
epigenetic effects of a traditional knock-in at the endogenous loci (Tiyaboonchai et al.,
2014). However, it will not be sufficient to simply integrate NKO-ICER into the safeharbor location because it would be constitutively expressed and result in rapid apoptosis
of the cells. One solution offered by moving NKO-ICER to the safe-harbor location is
that NKO-ICER can be regulated by an inducible tetracycline promoter, otherwise known
as a Tet-on system (Takarabio Bio, US). This allows for cells to be treated with
doxycycline (a tetracycline analog) to trigger expression of NKO-ICER in a controlled
fashion. Similar methods have been demonstrated to induce expression of a transgene in
human pluripotent stem cells in-vitro, but to our knowledge has not been demonstrated in
tumorigenic cell types, let alone malignant melanomas.
One main challenge is that even with successful integration of NKO-ICER into
the AAVS1 safe-harbor region under an inducible Tet-on promoter; wild-type ICER will
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also be expressed endogenously. Thus, it would be difficult to discern the effects of
NKO-ICER in isolation. Therefore, it is necessary to first create a cell line with wild-type
ICER knocked out. To create a knockout cell line, it is required that a knockout be
specific and effective. The premise of this experiment was to design a scalable workflow
to address the specificity and effectiveness of an endogenous ICER knockout. One
challenge of creating such a knockout is that ICER originates from an intronic promoter
within the CREM gene. Thus, a major component of this study was in-depth analysis of
the knockout genomic loci; necessary to rule out any disruption to the exonic region of
CREM from NHEJ. This task was feasible using next-generation sequencing
accomplished through what is called ‘targeted re-sequencing’. The goal of targeted
resequencing is to amplify and sequence a subset of the genome potentially thousands of
times. The high resolution of targeted re-sequencing makes it is possible to theoretically
identify low level indels/SNP’s. In this experiment, two separate bioinformatic tools were
used to review the targeted re-sequencing data, but did not reveal any noteworthy
mutations. Future experiments should attempt to increase the scale and transfection
efficiency of cells, as well as, utilize qualitative measures of success of genetic editing
(such as the T7 endonuclease assay) prior to DNA sequencing.
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Materials and Methods
Cell Culture, Transfection and DNA Extraction
A 20bp locus specific sequence for the guide RNA (gRNA)
(5’-CTGTCTGCAGAAGCCCATTA-3’) was designed using CHOPCHOP, an online
web tool for genome editing (Montague et al., 2014). The gRNA was inserted into the allin-one plasmid pCas9-GFP (Sigma Aldrich) in the experimental group. pCas9-GFP
contained a U6 promoter for gRNA expression, and CMV for expression of Cas9-GFP
(See Fig. 1). The control plasmid pEGFP-N1 contained EGFP under a CMV promoter
(Fig. 2) Commercially available Homo sapien derived malignant melanoma cells, SKMEL-24 (ATCC® HTB-71™) were cultured exactly according to ATCC instructions and
transiently transfected using FuGENE® HD Transfection Reagent according to
manufacturer's instruction at an 8:2 ratio of plasmid DNA to Fugene reagent on 35-mm
dishes. Cells were lysed and DNA extracted using GeneArt™ Genomic Cleavage
Detection kit (Invitrogen) according to manufacturer's protocol. DNA was analyzed via
nanodrop spectrophotometer to evaluate DNA concentration and quality (A260/280 and
A260/230 respectively).
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Fig. 1 Plasmid map highlighting position of gRNA and Cas9-GFP under different
ubiquitous promoters. U6 is an RNA polymerase III promoter that is typically used in
expression of shRNA and is useful in gRNA synthesis because it does not get
polyadenylated.

Fig. 2 Plasmid Map of pEGFP-N1. One interesting thing to note, is that the EGFP is
under a CMV promoter similar to experimental plasmid.
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T7 endonuclease Assay
T7 endonuclease assay was performed according to GeneArt™ Genomic
Cleavage Detection kit (Invitrogen) protocol. Briefly, DNA was amplified using a Veriti
96-well Thermal Cycler (Thermo Fisher Scientific) with primers
(5’-CCTGTGACAAAGCAAATTGATG-3’ and 5’-AGGATTAGTGCCTCAGTCAAG3’) that created an off-center amplicon, relative to predicted cleavage site by Cas9
endonuclease. The total size of the predicted amplicon homohybrid was 408bp and the
expected sizes of the two fragments were 151bp and 257bp.1uL of PCR product was
added to 1uL of 10x Detection buffer and brought to a total volume of 10uL with
DNase/RNase free water. DNA was denatured and allowed to reanneal. Reannealing
creates heteroduplex that T7 Endonuclease recognizes and cleaves at those locations. T7
and water was added to heteroduplex mix and allowed to incubate at 37

for either 30

minutes or 45 minutes (see fig8). After incubation, mix was immediately added to lanes
of 2% E-Gel® EX Gel (Invitrogen) as well as Hi-Lo 1 KB DNA Ladder (Bionexus) and
allowed to run for E-Gel® iBase™ Power System (Invitrogen) for 30 minutes on low
voltage setting, as per manufacturer’s instructions.
Library Preparation
GTTGAACTGTGGTAGAGGAAACAAGACAGTTCTGTCTGCAGAAGCCCATTAT
GGCTGTAACTGGAGATGACACAGGTAAGAATGTTAAAGAGGGGTTTTCAGTT
AATTGTGCAGATTGTTTTGAAGTTTAGGAAGTATTCAGGAACATCTGAGTGTT
TCAGAAAGTGTTACTCTCCTAGTCACTTAGGTGTAAGACTTTTTTTGAAATAT
ACATCTATATATTCAGCTCACTTTGTTAGGGCATCTTAGTGTGATTGTTTC
Fig. 3 Predicted Amplicon for deep sequencing. ICER specific sequences for primers are
highlighted in yellow. 20 bp gRNA sequence is highlighted in blue, adjacent to PAM site
‘TGG’. The A immediately 5’ of the PAM site is the first base of the start codon (red
font) of ICER, and hence the target of locus specific DNA cleavage by CRISPR Cas9.
15

Gene specific primers (Forward 5’-GTTGAACTGTGGTAGAGGAAAC-3’ and
Reverse 5’-GAAACAATCACACTAAGATGCC-3’) for first stage PCR were designed
manually and confirmed to have sufficient melting temperature and little potential for
complementarity by primer-Blast (NCBI). Additional sequences (Forward overhang 5’TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3’ and Reverse primer overhang
5’-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3’) were concatenated to
the oligos listed above for downstream indexing, as per 16S metagenomic sequencing
protocol (Illumina, USA). Primer design also ensured that the anticipated cleavage site
would be incorporated into amplicon (See Fig. 3 in red) and allowed for sufficient space
on either end to allow for detection of larger indels. Primers were synthesized by
Eurofins, USA and resuspended with TE Buffer at 100 μM. PCR master mix for initial
PCR was created according to KAPA HiFi HotStart Ready Mix PCR Kit (KAPA
biosystems) reagent protocol. High-Fidelity Taq polymerase is required to reduce risk of
introducing a mutation and preserving integrity of the DNA during PCR. 14μL of Master
mix was kept on ice and 11μL of Genomic DNA from extraction protocol above was
combined in a 0.2mL PCR safe nuclease-free tube and low-cycle amplified according to
KAPA Hifi PCR Kit protocol (see table 1).
After PCR, 45uL of room temperature AMPure XP beads (Beckman Coulter)
were added directly to PCR reaction. Samples were placed on an Eppendorf thermomixer
at 20

and shaking at 1,800 rpm for two minutes, then sat for 10 minutes without

shaking. Tubes were placed on DynaMag magnetic separation rack for two minutes to
allow beads to move to one side of the magnet. After two minutes, supernatant was
carefully removed without disturbing the bead pellet. 200μL of freshly prepared 80%
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Ethanol was then added to each well, and tubes were moved back and forth on the
Dynamag magnet, so beads would move from one side to the other through the Ethanol
about 10 times in order to wash the beads. All Ethanol was removed, and a second
Ethanol wash was performed. Beads were allowed to dry for about two minutes, then
30μL of TE buffer was added to each well to elute DNA. Tubes were placed back on
Eppendorf thermomixer at 20

and shaking at 1,800 rpm for two minutes and sat

without shaking for three minutes. After three minutes, tubes were placed back on
Dynamag magnet for two minutes. Supernatant collected was cleaned up DNA product.
In preparation for paired-end DNA sequencing, in which all samples are pooled
together into a single tube, unique adaptors must first be attached to the end of each
amplicon for downstream sample identification. Illumina Nextera XT indexes, which can
produce up to 24 unique combinations of i5 and i7 indexes (see Fig.4) were used in this
experiment. Creation of a matrix (as shown in Fig. 4) ensures minimal overlap between
index tags and reduces risk of index read failure. In a clean 0.2mL PCR safe nuclease free
tube, 5μL of cleaned up Amplified DNA with overhang sequences was combined with
5μL of i5 and i7 indexes, 10μL of Nuclease free-water and 25μL of KAPA Hi-Fidelity
Hot start Taq Polymerase Ready Mix. Short 8 cycle PCR was performed to add on
indexes to each amplicon (see table 1).
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Table 1. Settings for first and second round PCR, as well as settings for library
quantification via qPCR

S517
S502
S503
S504

N701
N702
N703
N704
N705
N706
Sample 1
0
0
0
0
0
0
Sample 2
0
0
0
0
0
0
Sample 3
0
Sample 5
0
0
0
0
Sample 4
0
Sample 6

Fig. 4 Matrix for unique selection of Nextera indexes to be ligated to amplicon. In
paired-end sequencing, little overlap between identical indexes is ideal to reduce the risk
of downstream index read failure. This matrix allows for not only unique combinations of
indexes but ensures diversity in first base of index called.

Table. 2 Sample ID table showing same name with corresponding index tags.
After indexing PCR, 45μL AMPure XP beads were added to 30μL of PCR
product in a clean 8 tube strip and additional bead cleanup was performed as previously
described. Elution tube containing final libraries were labelled in a 1.5mL Eppendorf tube
and stored in -20

prior to sequencing.
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Library Quantification
Final libraries were quantified via real-time PCR (qPCR) according to KAPA
Library Quantification Kit Illumina® Platforms instructions. Briefly, ‘ROX high’ passive
reference dye was added to KAPA SYBR FAST qPCR Master Mix. 12.4μL of Master
mix was added to MicroAmp™ Fast Optical 96-Well Reaction Plate (Applied
Biosystems) with 3.6uL of Nuclease-free water and 4μL of each sample (ran in triplicate)
diluted 1:10,000 along with a no template control (NTC) and PhiX as a positive control
whose concentration was known to be 10nM. Real-time PCR was performed on
StepOnePlus™ Real-Time PCR System programmed for an initial denature for 5 minutes
at 95

and then 35 cycles of 95

for 30 seconds and 45 seconds at 60

for

annealing/extension and data acquisition (see table. 1). No melt curve was performed
during this QC. Mean Ct value for each of the six controls was plotted on a line with the
log (known concentration) with an R² value ~0.999. From this line, the Y-intercept and
slope were derived and mean Ct for each sample was put into equation to determine each
sample concentration in nM. Final concentration was determined using the average size
of amplicon derived from Tapestation.
Sample size was quantified via Agilent TapeStation 2200. 2μL of final libraries
was combined with 2μL of High Sensitivity buffer (Agilent) and ran using High
Sensitivity DNA Tape (Agilent). Regions were set from 200 to 700 bp.
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Pooling and Sequencing
All samples were normalized to 2nM based on concentrations derived from
library quantification via qPCR. 5μL from each diluted library was pooled together into a
single 1.5mL Eppendorf tube. 20μL of the pooled amplicon library was added to a 0.2mL
PCR tube. In another tube, 20μL of 2nM PhiX was added. PhiX is commonly used in
next-generation sequencing experiments to diversify libraries. Both tubes were denatured
at 95ºC for five minutes, then tubes were placed on ice for five minutes. 20μL of freshly
prepared 0.1M NaOH was added to each tube (reducing concentration of each pool to
1nM. Final loading concentration was empirically determined based on previous
sequencing runs and corresponding cluster densities and concluded to be 5pM. From the
diluted library tube, 20% of the final volume was removed and discarded and replaced
with diluted denatured PhiX control as a 20% spike in. 600uL of final denatured pool was
added to Miseq Reagent Kit v3 (600-cycle) and performed 200x8x8x200 sequencing
under amplicon chemistry.
Bioinformatic analysis
Initial analysis of CRISPR Cas9 mediated knockout of ICER was performed
using CRISPResso, an online computation pipeline for detection of SNP’s and indels on
target regions by direct comparison of raw paired-end FASTQ files and predicted
amplicon (Pinello et al., 2016). Read 1 and Read 2 FASTQ files were retrieved from
Basespace sequence hub (Illumina, USA), and uploaded onto CRISPResso online
interface along with predicted amplicon (see Fig. 3) and gRNA sequence (5’CTGTCTGCAGAAGCCCATTA-3’) with no window surrounding predicted cleavage
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site, minimum average read and base quality of phred ≥30, and no exclusions from either
side of predicted cut site. No trimming of adaptor sequences was required because this
function was performed via Basespace Sequence Hub.
Additional bioinformatic analysis using bowtie and SAMtools was performed to
confirm CRISPResso results and to investigate the output data more thoroughly.
Ultimately these bioinformatic tools enable creation of human genome indexed .BAM
files; a file type compatible with Integrative Genome Browser or IGV (Broad Institute)
for visualization of sequence data and variant calling/confirmation. Briefly, Sequence
Alignment to reference human genome GRCh38 was created with bowtie (Johns Hopkins
University) running from Bioconda using terminal on MacOS 10.12.6. Output file from
reference genome alignment was .SAM file, and subsequently converted to .BAM file
which is much more efficient for storage because it converts sequence to a binary file.
Reads from each file were filtered for quality based on phred score (Q30). Only bases
with >=Q30 were kept, minimizing background. BAM file outputs from Read 1 and Read
2 were then merged together using SAMtools to overlap based on previously specified
sequencing parameters (200x8x8x200). Merged files were then sorted according to
FASTA for GRCh38 reference human genome.
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Fig. 5 Flow chart describing general workflow for manipulating sequencing output file in
preparation for variant calling. Final output from this bioinformatic pipeline is an indexed
.BAM file that can be directly interpreted by IGV to display corresponding basecalls.
22

Results
Transfection efficiency
Both control and experimental samples expressed GFP see figures 6 through 7.
Expression of GFP suggests that gRNA and Cas9 were also expressed because they
originate from the same plasmid. Transfection efficiency for both groups was between 20
and 40%.

Fig. 6a Brightfield Control SK-MEL-24 cells at 10x magnification.

Fig. 6b FITC Control SK-MEL-24 under same magnification as brightfield. Transfection
efficiency of cells was determined to be roughly 30%.
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Fig. 7a Brightfield Experimental SK-MEL-24 cells at 10x magnification.

Fig. 7b FITC Experimental SK-MEL-24 cells under same magnification as brightfield.
Transfection efficiency of cells was determined to be roughly 30%.
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T7 Endonuclease Assay
No distinct bands smaller than initial PCR product were identified from T7
Endonuclease assay (see Fig. 8), which suggests no genomic cleavage by CRISPR Cas9.
Although the sensitivity of this assay is limited, this can be used as a good predictor of
experimental success. A time course of DNA incubation with T7 endonuclease was
performed to rule out non-specific cleavage by T7. Even after only 30 minutes of
incubation, the control sample (Fig. 8 lane 3) (that should not create heteroduplexes) was
recognized and appears to be cleaved by T7, as evident by a smear on the lane when
compared to control without T7 in lane 4 (Fig. 8). Thus, with this high level of
background, T7 endonuclease may require much higher transfection efficiency for
efficient identification of indels/substitutions.
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Fig. 8 2% E-gel from T7 endonuclease assay. Description of lanes are found in Table
below. To determine if there was any non-specific cleavage after extended incubation
with T7 endonuclease, each group was exposed +/- enzyme and also with varying degree
of time (30 or 45 minute incubation).
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Library Quantification

Fig. 9 Highsensitivity TapeStation QC. From left: High Sensitivity Ladder, Experimental
after first round PCR, Control after first round PCR, Experimental after round 2 PCR,
Control after Round 2 PCR. Increase in base pair size suggests successful addition of
index adaptors to amplicon after second round PCR. Final amplicon size was ~377bp.

27

Bioinformatic analysis

Fig. 10 Graph from basespace showing %reads per sample with corresponding unique
index assignments. This graph was primarily used to determine which set of control and
experimental samples to be used for direct bioinformatic comparison. Index 5 and Index
6 corresponding to Experimental 3 and Control 3, respectively contain comparable
number of reads.

Fig. 11 Chart showing Quality metrics from Basespace. While clusters passing filter rate
was quite high 95.3, the cluster density of run was on the low end ~ 380 /
.

Fig. 12 Chart showing Yield metrics from Basespace. Of note, the total yield 3.85giga
bases and 24.99 aligned. This number of alignments should be similar to percent of PhiX
spike in, which was 20%. Of the 3.85giga base yield, greater than 90% were >=Q30.
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CRISPResso analysis did not reveal any significant changes in experimental
sequence that would suggest successful editing via CRISPR Cas9. One single C->T
substitution appears in 0.2% of all sequence reads according to CRISPResso output (see
Fig. 16), but this does not represent a notable change in sequence.

Fig. 13 Control 3 showing the frequency and distribution of insertions, deletions, and
substitutions.

Fig.14 Experimental 3 showing the frequency and distribution of insertions, deletions,
and substitutions.
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Fig. 15 Results from CRISPResso showing number of reads that align directly to the
reference from Control sample and any substitutions/indels within a window from
predicted cleavage site.

Fig. 16 Results from CRISPResso showing number of reads that align directly to the
reference from Experimental sample and any substitutions/indels within a window from
predicted cleavage site.
A custom bioinformatic pipeline using Bowtie and SAMtools was created in order
to identify whether any sequences were missed by CRISPResso’s algorithm in
determining how efficient CRISPR Cas9 was at mediating genetic alteration. These
analyses were performed as described above s to render the paired-end FASTQ files in a
suitable file format for visualization using IGV. Indexed samples 5 and 6 were directly
compared using IGV as shown in Fig. 17 with the Experimental sample on top and
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Control sample on the bottom. CRISPResso identified the same low-level variant in
experimental sample but failed to display the level of detail achieved by IGV. In addition,
the exact location of this substitution varies between the two results. CRISPResso
displays this substitution as C->T, but when mapped to human genome reference
GRCh38, IGV displays this substitution as A->T (See Fig. 17). Other lower level variants
were identified with IGV that were not shown by CRISPResso, but none were considered
statistically significant or near the start codon. This suggests that although more of these
low level variants were identified in experimental samples compared to the control, they
are most likely PCR artifacts and not the result of CRISPR Cas9 mediated genetic
alteration.
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Fig. 17 Screenshot of Integrative Genome Browser (IGV) corroborating CRISPResso
result of low-level variant although when mapped to human genome, it appears this
variant is mapped one bp off compared to CRISPResso output.
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Discussion
Inducible cAMP Early Repressor (ICER) is a putative tumor suppressor that is
actively targeted for proteasomal degradation, most likely through ubiquitination.
Melanoma cells rapidly apoptosed when transfected with a mutant form of ICER that did
not contain any lysine residues. This suggests that in diseased cells, such as malignant
melanoma (and other cancers), that the cell recognizes ICER as an imminent threat to cell
proliferation. Unfortunately, due to apparent rapid apoptosis, protecting ICER from
degradation or subcellular relocation alone is insufficient as a model system. This issue
compounds the need for an inducible expression system, in which expression of ICER
can be regulated so that further investigation can identify how ICER plays a role in
cancer growth. To accomplish this task, wild type ICER should be effectively knocked
out to be able to characterize the role of NKO-ICER exclusively. In this thesis, an ICER
knockout was attempted using transient transfection with an all in one plasmid containing
a gRNA designed to direct Cas9 to the start codon of ICER. While transfection efficiency
of the cells appeared promising, targeted resequencing of this locus many times did not
suggest any endonucleolytic activity by Cas9. While no notable differences were
identified between the experimental and control group in this particular experiment, a
successful workflow for carrying out and analyzing targeted re-sequencing data of
CRISPR Cas9 mediated genetic alteration was developed. In doing so, it was identified
that sequencing results can differ depending on human genome reference. For example,
CRISPResso a bioinformatics tool that compares sequence data directly to a reference
sequence could be different from a more in-depth analysis which maps sequence data to
the coordinates of a reference genome. In this experiment, this subtle difference of one
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nucleotide that was present a minority of the time did not change the outcome, but it is
not impossible that this difference could be significant in other instances.
Future experiments would take into consideration number of clone’s transfected
and screened. It may be required to isolate many different clones and screen hundreds to
identify a genotype sufficient for our purposes of creating a knockout cell line. One
advantage is that this workflow is easily scalable and so more in-depth screening is
certainly possible. It is plausible that this particular gRNA sequence is not compatible
with this cell type. In this case, it may be required to explore different Cas9 species that
originate from within different bacterial strains. The Cas9 in this experiment was of the
most widely used variety, Streptococcus pyogenes, but different Cas9 species would
recognize different PAM sites, providing more flexibility in terms of gRNA design and
thus Cas9 endonuclease activity. In addition, it has not escaped my knowledge that more
sophisticated bioinformatic tools exist and could be used in this application. Further work
will be done to incorporate such tools into this workflow to rapidly and accurately
identify indels and substitutions from CRISPR Cas9.
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